Survival prognosis of hiv-infected patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 6, Issue 6, 1993, Pages 624-629

  Hanson, Debra L ^a   Horsburgh, C Robert ^a,b   Fann, S Alan ^b   Havlik, Joseph A ^b   Thompson, Sumner E ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS indicating diseases; Antiretroviral therapy; CD4 T lymphocytes; Human immunodeficiency virus (HIV); Pooled logistic regression; Survival analysis

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; REGRESSION ANALYSIS; STATISTICAL MODEL; SURVIVAL; T LYMPHOCYTE; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GEORGIA; HIV INFECTIONS; HIV-1; HUMAN; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; ODDS RATIO; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 0027309311     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Rothenberg R, Woelfel M, Stoneburner R, Milberg J, Parker R, Truman B. Survival with the acquired immunodeficiency syndrome: experience with 5, 833 cases in New York City. N Engl J Med 1987; 317:1297–302.
2. Bacchetti P, Osmond D, Chaisson RE, et al. Survival patterns of the first 500 AIDS cases in San Francisco. J Infect Dis 1988; 157:1044–7.
3. Lemp G, Payne S, Neal D, Temelso T, Rutherford G. Survival trends for patients with AIDS. JAMA 1990; 263:402–6.
4. Moss AR, McCallum G, Volberding PA, Bacchetti P, Dritz S. Mortality associated with mode of presentation in the acquired immune deficiency syndrome. J Natl Cancer Inst 1984; 73:1281–4.
5. Kaplan J, Spira T, Fishbein D, Bozeman L, Pinsky P, Schonberger L. A six-year follow-up of HIV-infected homosexual men with lymphadenopathy: evidence for an increased risk for developing AIDS after the third year of lymphadenopathy. JAMA 1988; 260:2694–7.
6. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36(1S):3S–15S.
7. Abbott R. Logistic regression in survival analysis. Am J Epidemiol 1985; 121:465–71.
8. D’ Agostino R, Lee M, Belanger A, Cupples LA, Anderson K, Kannel W. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med 1990; 9:1501–15.
9. Bacchetti P, Osmond D, Chaisson R, Moss A. Correspondence. Survival with AIDS in New York. New Engl J Med 1988:1464–5.
10. Farizo K, Buehler J, Chamberland M, et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992; 267:1798–806.
11. Lemp G, Hirozawa A, Araneta M, Young K, Nieri G. Improved survival for persons with AIDS in San Francisco (TU.C.41 Abstract). Volume 1. Presented at the Seventh International Conference on AIDS, Florence, Italy, 1991.
12. Moore R, Hidalgo J, Sugland B, Chaisson R. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med 1991; 324:1412–6.
13. Volberding P, Lagakos S, Koch M, Pettinelli C. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990; 322:941–9.
14. Fischi M, Richman D, Grieco M, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durack DT, King D, and the AZT Collaborative Working Group. The efficacy of azido-thymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987; 317:185–91.
15. Graham N, Zeger S, Park L, et al. The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med 1992; 326:1037–42.
16. Larder B, Darby G, Richman D. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989; 243:1731–4.